Does CABOZANTINIB S-MALATE Cause Off label use? 5,245 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,245 reports of Off label use have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 13.4% of all adverse event reports for CABOZANTINIB S-MALATE.
5,245
Reports of Off label use with CABOZANTINIB S-MALATE
13.4%
of all CABOZANTINIB S-MALATE reports
591
Deaths
633
Hospitalizations
How Dangerous Is Off label use From CABOZANTINIB S-MALATE?
Of the 5,245 reports, 591 (11.3%) resulted in death, 633 (12.1%) required hospitalization, and 34 (0.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 5,245 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
Death (2,504)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Off label use Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE